Bristol-Myers Squibb NCT01928394 Can you Help Patricia?

Bristol Myers Squibb sponsors a study A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab in Subjects With Advanced or Metastatic Solid Tumors

Can you help Patricia?

She is a 60 year old cancer patient currently at MDA.  Here is a little bit about her:

 

Two years ago she got Metaplastic Breast Cancer.  Sub-type Carcinsarcoma Triple Negative.  She was Stage 3.  She had a mastectomy and 49 out of 50 lymph nodes were positive.

After A/C she was cancer free for one year.

However, the cancer has returned  in her bones.  She is determined to beat this and is very interested in this trial.  However, she has not been offered it.  Her daughter has been able to contact the right people and I am reaching out for help. 

Please contact me if possible, asap.  Her pathology is very interesting and I am sure would add amazing value to the study.  The new cancer biopsy states metastatic cancer and not metaplastic.  So she falls into your criteria.

 

 

 

Comments

[judy wilson]

I implore Bristol Myers to accept this woman into its study. We all need your help, Bristol Myers. Please don't turn away fromthis woman who has worked so hard and long to fight this disease, not just for herself, but for all of us behind her who are looking for hope....